Palmetto announced: 1) updates to its biotheranostics cancer type identifier for RT-PCR 92-gene assay and 2) a multiple procedure payment reduction on certain diagnostic imaging procedures. April 27, 2012
The J11 A/B MAC Medical Review department will perform a service-specific prepay probe review on outpatient claims in North Carolina, South Carolina, Virginia, and West Virginia. Data analysis identified 13 oncology radiation therapy outpatient services with significant frequency in these states. Further analysis indicated certain procedure codes as most frequently billed codes for oncology radiation therapy. Claims review will be performed on approximately 100 claims per state for each of the procedure codes selected. April 17, 2012
The J11 A/B MAC Medical Review department will perform a service-specific prepay probe review on outpatient claims in North Carolina, South Carolina, Virginia, and West Virginia. Data analysis identified 17 hematology/oncology (other drugs) outpatient services with significant frequency in these states. Further analysis indicated certain procedure codes as most frequently billed codes hematology/oncology (other drugs). Claims review will be performed on approximately 100 claims per state for each of the procedure codes selected. April 17, 2012
The Oncotype DX Colon Cancer Assay, developed to predict the recurrence risk for patients with Stage II colon cancer, has been assigned a unique identifier. To bill an Oncotype DX Colon service, please provide the claim information listed in this article. March 26, 2012
